World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

Table 3 Vaccination rate following HBV screening by sex and age group

Variables	Vaccinated^a/Total	%	1st dose	2nd dose	3rd dose	Mean age
Sex
Female	668/1139	58.6	675	672	668	29.8 ± 13.8
Male	534/847	63.0	545	535	534	30.1 ± 14.1
Total	1202/1986	60.5	1220	1207	1202	24.6 ± 4.7
Age
≤ 20	210/474	44.3	215	211	210	12.8 ± 5.4
21–30	436/664	65.7	441	437	436	26.1 ± 2.8
31–40	316/459	68.8	318	317	316	35.0 ± 2.8
41–50	119/192	62.0	122	120	119	45.0 ± 2.8
> 50	121/197	61.4	124	122	121	57.5 ± 6.0
Number of vaccinated individuals
Female	668/1202	55.6	675	672	668	29.5 ± 12.7
Male	534/1202	44.4	545	535	534	30.1 ± 11.2
Vaccination rate
Female	668/1986	33.6	675	672	668	29.8 ± 13.8
Male	534/1986	26.9	545	535	534	29.9 ± 13.9

^aAll vaccinated HBsAg individuals completed their three doses of hepatitis B vaccine

ISSN: 1743-422X